Shoam, Israel

Lev Rosenblit

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Lev Rosenblit: Innovator in Encryption Technologies

Introduction

Lev Rosenblit is a notable inventor based in Shoam, Israel. He has made significant contributions to the field of encryption technologies, holding a total of 5 patents. His work focuses on enhancing security measures in online communication, particularly in multiparty conference settings.

Latest Patents

Rosenblit's latest patents include innovative methods for managing end-to-end encryption in online meetings. One of his patents describes a computer-implemented method for dynamically disabling an end-to-end encryption session during an online meeting. This method involves sending encrypted instructions to a key orchestration server to disable the encryption while maintaining the meeting session. Another patent outlines a method for encrypting data records and processing them without exposing plaintext. This involves generating a keyset based on a master key and securely distributing it to client devices.

Career Highlights

Throughout his career, Lev Rosenblit has worked with various companies, including RingCentral, Inc. His experience in the tech industry has allowed him to develop and refine his innovative ideas in encryption technologies.

Collaborations

Rosenblit has collaborated with notable professionals in the field, including Aviad Lahav and Danil Artemov. These collaborations have contributed to the advancement of his projects and patents.

Conclusion

Lev Rosenblit is a prominent figure in the realm of encryption technologies, with a focus on enhancing security in online communications. His innovative patents reflect his commitment to improving the safety and efficiency of digital interactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…